Modelling & Simulation SIG

The Modelling and Simulation Special Interest Group is a forum to share knowledge and understanding about statistical modelling and simulation related to pharmaceutical development.

Publications:

  • Predictive event modelling in multicenter clinical trials with waiting time to response, Vladimir V. Anisimov DOI: 10.1002/pst.525 Pharmaceutical Statistics Special Issue: Focusing on the PSI Special Interest Groups Volume 10, Issue 6, pages 517–522, November/December 2011
  • Modelling and simulation in the pharmaceutical industry—some reflections, Carl-Fredrik Burman, Stig Johan Wiklund DOI: 10.1002/pst.523 Pharmaceutical Statistics Special Issue: Focusing on the PSI Special Interest Groups Volume 10, Issue 6, pages 508–516, November/December 2011
  • V. Anisimov, Effects of unstratified and centre-stratified randomization in multicentre clinical trials, Pharmaceutical Statistics, v. 10, iss. 1, 2011, pp. 50-59.
  • V. Anisimov, Drug supply modeling in clinical trials (statistical methodology), Pharmaceutical Outsourcing, May/June, 2010, pp. 50-55.
  • V. Anisimov, Predictive modelling of recruitment and drug supply in multicenter clinical trials, Proc. of the Joint Statistical Meeting, Washington, USA, August, 2009, pp. 1248-1259.
  • V. Anisimov, Recruitment modeling and predicting in clinical trials, Pharmaceutical Outsourcing, March/April 2009, Vol. 10, Issue 1, pp. 44-48.
  • V. Anisimov, Effects of unstratified and centre-stratified randomization in multicentre clinical trials, Pharmaceutical Statistics v.10, iss. 1, 2011, pp.50-59
  • V. Anisimov, Impact of stratified randomization in clinical trials, In: Giovagnoli A., Atkinson AC., Torsney B. (Eds), MODA 9 - Advances in Model-Oriented Design and Analysis. Physica-Verlag/Springer, Berlin, 2010, pp. 1-8.
  • S. Senn, V. Anisimov, V. Fedorov, Comparisons of minimisation and Atkinson's algorithm, Statistics in Medicine, 2010, V. 29, issue 7/8, pp. 721-730.
  • V. Anisimov, V. Fedorov, Modeling, prediction and adaptive adjustment of recruitment in multicentre trials, Statistics in Medicine, v. 26, No 27, 2007, pp. 4958-4975.

Coming soon:

Autumn 2014 - Making Modelling and Simulation Work for Regulators and Industry: This one day meeting will be a forum for examining how industry can best present our model-derived predictions to regulators.

External Links:

Recent Activity

Latest News


  • Stats Excellence in the Pharmaceutical Industry award 2017

    We are very pleased to announce that the winner of the 2017 Statistical Excellence in the Pharmaceutical Industry Award goes to Dr Michael O’Kelly, principal scientific advisor at QuintilesIMS.
    more»
  • PSI Conference - Winners of this year's Poster Prize

    The 2017 PSI conference was held in London last week with a record attendance and fantastic scientific content. For those of you who missed the Close of the Conference, Anna Berglind from AstraZeneca presented the winners of this year's Poster Prize. We had 53 posters, and the quality of posters was very high.
    more»
Show all news

EventsFuture Events


Chiltern Logo Horz_TaglineRegistered_Screen

Biostatistician / Senior Biostatistician

read more...

Resized PAREXEL Logo with Tagline_Small_Full Color

Senior/Principal Biostatistician

read more...

Merck Logo2

Associate Director, Biostatistician

read more...

Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...